| 1 |
Vincent JL, Castro P, Hunt BJ, et al. Thrombocytopenia in the ICU: disseminated intravascular coagulation and thrombotic microangiopathies—what intensivists need to know [J]. Crit Care, 2018, 22(1): 158.
|
| 2 |
Zarychanski R, Houston DS. Assessing thrombocytopenia in the intensive care unit: the past, present, and future [J]. Hematology Am Soc Hematol Educ Program, 2017, 2017(1): 660-666.
|
| 3 |
Iba T, Levy JH, Raj A, et al. Advance in the management of sepsis-induced coagulopathy and disseminated intravascular coagulation [J]. J Clin Med, 2019, 8(5): 728.
|
| 4 |
Thiolliere F, Serre-Sapin AF, Reignier J, et al. Epidemiology and outcome of thrombocytopenic patients in the intensive care unit: results of a prospective multicenter study [J]. Intensive Care Med, 2013, 39(8): 1460-1468.
|
| 5 |
中国临床肿瘤学会肿瘤化疗所致血小板减少症共识专家委员会. 肿瘤化疗所致血小板减少症诊疗中国专家共识(2018版) [J]. 中华肿瘤杂志, 2018, 40(9): 714-720.
|
| 6 |
中国临床肿瘤学会(CSCO)抗白血病联盟, 中国临床肿瘤学会(CSCO)抗淋巴瘤联盟. 急性白血病化疗所致血小板减少症诊疗中国专家共识 [J]. 白血病·淋巴瘤, 2019, 28(4): 193-197.
|
| 7 |
中华医学会血液学分会止血与血栓学组. 成人原发免疫性血小板减少症诊断与治疗中国专家共识(2016年版) [J]. 中华血液学杂志, 2016, 37(2): 89-93.
|
| 8 |
Menard CE, Kumar A, Houston DS, et al. Evolution and impact of thrombocytopenia in septic shock: a retrospective cohort study [J]. Crit Care Med, 2019, 47(4): 558-565.
|
| 9 |
Thachil J. Disseminated intravascular coagulation: a practical approach [J]. Anesthesiology, 2016, 125(1): 230-236.
|
| 10 |
Alhamdi Y, Abrams ST, Lane S, et al. Histone-associated thrombocytopenia in patients who are critically ill [J]. JAMA, 2016, 315(8): 817-819.
|
| 11 |
Charri A, Medhioub F, Samet M, et al. Thrombocytopenia in critically ill patients: a review of the literature [J]. Anaesth Crit Care Pain Med, 2011, 1(4): 199-202.
|
| 12 |
Chang JC. Disseminated intravascular coagulation: is it fact or fancy? [J]. Blood Coagul Fibrinolysis, 2018, 29(3): 330-337.
|
| 13 |
Gando S, Levi M, Toh CH. Disseminated intravascular coagulation [J]. Nat Rev Dis Primers, 2016, 2: 16037.
|
| 14 |
Levi M, Scully M. How I treat disseminated intravascular coagulation [J]. Blood, 2018, 131(8): 845-854.
|
| 15 |
Warkentin TE. Heparin-induced thrombocytopenia in critically ill patients [J]. Semin Thromb Hemost, 2015, 41(1): 49-60.
|
| 16 |
Fuchs TA, Bhandari AA, Wagner DD. Histones induce rapid and profound thrombocytopenia in mice [J]. Blood, 2011, 118(13): 3708-3714.
|
| 17 |
Thiery-Antier N, Binquet C, Vinault S, et al. Is thrombocytopenia an early prognostic marker in septic shock [J]? Crit Care Med, 2016, 44(4): 764-772.
|
| 18 |
Menard CE, Kumar A, Houston DS, et al. Evolution and impact of thrombocytopenia in septic shock: a retrospective cohort study [J]. Crit Care Med, 2019, 47(4): 558-565.
|
| 19 |
Xie Y, Tian R, Xie H, et al. The clinical significance of thrombocytopenia complicating sepsis: a meta-analysis [J]. J Infect, 2019, 78(4): 323-337.
|
| 20 |
Claushuis TA, van Vught LA, Scicluna BP, et al. Thrombocytopenia is associated with a dysregulated host response in critically ill sepsis patients [J]. Blood, 2016, 127(24): 3062-3072.
|
| 21 |
Moreau D, Timsit JF, Vesin A, et al. Platelet count decline: an early prognostic marker in critically ill patients with prolonged ICU stays [J]. Chest, 2007, 131(6): 1735-1741.
|
| 22 |
Venkata C, Kashyap R, Farmer JC, et al. Thrombocytopenia in adult patients with sepsis: incidence, risk factors, and its association with clinical outcome [J]. J Intensive Care, 2013, 1(1): 9.
|
| 23 |
Akca S, Haji-Michael P, de Mendonca A, et al. Time course of platelet counts in critically ill patients [J]. Crit Care Med, 2002, 30(4): 753-756.
|
| 24 |
Durila M, Kalincik T, Jurcenko S, et al. Arteriovenous differences of hematological and coagulation parameters in patients with sepsis [J]. Blood Coagul Fibrinolysis, 2010, 21 (8): 770-774.
|
| 25 |
Ostrowski SR, Windelov NA, Ibsen M, et al. Consecutive thrombelastography clot strength profiles in patients with severe sepsis and their association with 28-day mortality: a prospective study [J]. J Crit Care, 2013, 28 (3): 311-317.
|
| 26 |
Muzaffar SN, Baronia AK, Azim A, et al. Thromboelastography for evaluation of coagulopathy in nonbleeding patients with sepsis at intensive care unit admission [J]. Indian J Crit Care Med, 2017, 21 (5): 268-273.
|
| 27 |
Saini A, Spinella PC, Ignell SP, et al. Thromboelastography variables, immune markers, and endothelial factors associated with shock and NPMODS in children with severe sepsis [J]. Front Pediatr, 2019, 7: 422.
|
| 28 |
Massion PB, Peters P, Ledoux D, et al. Persistent hypocoagulability in patients with septic shock predicts greater hospital mortality: impact of impaired thrombin generation [J]. Intensive Care Med, 2012, 38 (8): 1326-1335.
|
| 29 |
Sivula M, Pettila V, Niemi TT, et al. Thromboelastometry in patients with severe sepsis and disseminated intravascular coagulation [J]. Blood Coagul Fibrinolysis, 2009, 20 (6): 419-426.
|
| 30 |
Brenner T, Schmidt K, Delang M, et al. Viscoelastic and aggregometric point-of-care testing in patients with septic shock - cross-links between inflammation and haemostasis [J]. Acta Anaesthesiol Scand, 2012, 56 (10): 1277-1290.
|
| 31 |
Stanworth SJ, Navarrete C, Estcourt L, et al. Platelet refractoriness--practical approaches and ongoing dilemmas in patient management [J]. Br J Haematol, 2015, 171(3): 297-305.
|
| 32 |
Moncharmont P. Platelet component transfusion and alloimmunization: Where do we stand? [J]. Transfus Clin Biol, 2018, 25(3): 172-178.
|
| 33 |
Warner MN, Moore JC, Warkentin TE, et al. A prospective study of protein-specific assays used to investigate idiopathic thrombocytopenic purpura [J]. Br J Haematol, 1999, 104(3): 442-447.
|
| 34 |
Hagenström H, Schlenke P, Hennig H, et al. Quantification of platelet-associated IgG for differential diagnosis of patients with thrombocytopenia [J]. Thromb Haemost, 2000, 84(5): 779-783.
|
| 35 |
Yang YF. Analysis of the correlations between immunological changes and syndrome groups in patients with immunological thrombocytopenic purpura (ITP) [J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 1992, 12(5): 263-259.
|
| 36 |
Ware R, Kinney TR, Friedman HS, et al. Prognostic implications for direct platelet-associated IgG in childhood idiopathic thrombocytopenic purpura [J]. Am J Pediatr Hematol Oncol, 1986, 8(1): 32-37.
|
| 37 |
Lassila R. Platelet function tests in bleeding disorders [J]. Semin Thromb Hemost, 2016, 42(3): 185-190.
|
| 38 |
许晓巍, 李岩, 贡伟, 等. 脓毒症凝血功能异常的发生率和临床意义 [J]. 临床急诊杂志, 2010, 11(4): 232-233;232-233, 236.
|
| 39 |
Asakura H, Takahashi H, Uchiyama T, et al. Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis [J]. Thromb J, 2016, 14: 42.
|
| 40 |
Yamakawa K, Umemura Y, Murao S, et al. Optimal timing and early intervention with anticoagulant therapy for sepsis-induced disseminated intravascular coagulation [J]. Clin Appl Thromb Hemost, 2019, 25: 1076029619835055.
|
| 41 |
Iba T, Nisio MD, Levy JH, et al. New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey [J]. BMJ Open, 2017, 7(9): e017046.
|
| 42 |
Machlus KR, Thon JN, Italiano JE Jr. Interpreting the developmental dance of the megakaryocyte: a review of the cellular and molecular processes mediating platelet formation [J]. Br J Haematol, 2014, 165(2): 227-236.
|
| 43 |
Zang C, Luyten A, Chen J, et al. NF-E2, FLI1 and RUNX1 collaborate at areas of dynamic chromatin to activate transcription in mature mouse megakaryocytes [J]. Sci Rep, 2016, 6: 30255.
|
| 44 |
Roweth HG, Parvin S, Machlus KR. Megakaryocyte modification of platelets in thrombocytopenia [J]. Curr Opin Hematol, 2018, 25(5): 410-415.
|
| 45 |
Decousus H, Tapson VF, Bergmann JF, et al. Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators [J]. Chest, 2011, 139(1): 69-79.
|
| 46 |
Rosenberg D, Eichorn A, Alarcon M, et al. External validation of the risk assessment model of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) for medical patients in a tertiary health system [J]. J Am Heart Assoc, 2014, 3(6): e001152.
|
| 47 |
Hostler DC, Marx ES, Moores LK, et al. Validation of the international medical prevention registry on venous thromboembolism bleeding risk score [J]. Chest, 2016, 149(2): 372-379.
|
| 48 |
Greinacher A, Selleng S. How I evaluate and treat thrombocytopenia in the intensive care unit patient [J]. Blood, 2016, 128(26): 3032-3042.
|
| 49 |
Droege CA, Ernst NE, Messinger NJ, et al. Evaluation of Thrombocytopenia in critically ill patients receiving continuous renal replacement therapy [J]. Ann Pharmacother, 2018, 52(12): 1204-1210.
|
| 50 |
Ferreira JA, Johnson DW. The incidence of thrombocytopenia associated with continuous renal replacement therapy in critically ill patients [J]. Ren Fail, 2015, 37(7): 1232-1236.
|
| 51 |
Guru PK, Singh TD, Akhoundi A, et al. Association of thrombocytopenia and mortality in critically ill patients on continuous renal replacement therapy [J]. Nephron, 2016, 133(3): 175-182.
|
| 52 |
Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin [J]. N Engl J Med, 1995, 332(20): 1330-1335.
|
| 53 |
Lefrançais E, Ortiz-Muñoz G, Caudrillier A, et al. The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors [J]. Nature, 2017, 544(7648): 105-109.
|
| 54 |
Zhang J, Lu Z, Xiao W, et al. Efficacy and safety of recombinant human thrombopoietin on sepsis patients with thrombocytopenia: a systematic review and meta-analysis [J]. Front Pharmacol, 2020, 11: 940.
|
| 55 |
Wu Q, Ren J, Wu X, et al. Recombinant human thrombopoietin improves platelet counts and reduces platelet transfusion possibility among patients with severe sepsis and thrombocytopenia: a prospective study [J]. J Crit Care, 2014, 29(3): 362-366.
|
| 56 |
章渭方, 方君俊, 王国彬, 等. 重组人血小板生成素治疗脓毒症相关血小板减少症患者的临床研究 [J/CD]. 中华危重症医学杂志 (电子版), 2016, 9(5): 300-308.
|
| 57 |
Wang B, Yao F, Wang Y, et al. A multi-center clinical observation of recombinant human thrombopoietin for the treatment of sepsis-associated thrombocytopenia [J]. Int J Clin Exp Med, 2019, 12(5): 6324-6334.
|
| 58 |
Zhou Z, Feng T, Xie Y, et al. The effect of recombinant human thrombopoietin (rhTPO) on sepsis patients with acute severe thrombocytopenia: a study protocol for a multicentre randomised controlled trial (RESCUE trial) [J]. BMC Infect Dis, 2019, 19(1): 780.
|
| 59 |
中国老年医学学会, 国家老年疾病临床医学研究中心(解放军总医院), 解放军老年医学专业委员会.感染诱发的老年多器官功能障碍综合征诊断与治疗中国指南2019 [J]. 中华老年多器官疾病杂志, 2019, 18(11): 801-838.
|
| 60 |
Kaushansky K. Thrombopoietin [J]. N Engl J Med, 1998, 339(11): 746-754.
|
| 61 |
Wan B, Zhang H, Fu H, et al. Recombinant human interleukin-11 (IL-11) is a protective factor in severe sepsis with thrombocytopenia: a case-control study [J]. Cytokine, 2015, 76(2): 138-143.
|
| 62 |
Tepler I, E1ias L, Hussein M, et al. A randomized placebo controlled trial of recombinant human intedeukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy [J]. Blood, 1996, 87(9): 3607-3614.
|
| 63 |
Isaacs C, Robert NJ, Bailey FA, et al. Randomized placebo controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicin [J]. J Clin Oncol, 1997, 15(11): 3368-3377.
|
| 64 |
Polovich M, Whitford JM, olsen M, et al. Chemotherapy and biotherapy guidelines and recommendations for practice [M]. 4th ed. Oncology Nursing Society, 2014.
|
| 65 |
Jin C, Wang Y, Cheng H, et al. Platelet and peripheral white blood cell counts at diagnosis predict the response of adult immune thrombocytopenia to recombinant human interleukin-11: A retrospective, single-center, case-control study [J]. Medicine (Baltimore), 2019, 98(16): e15195
|
| 66 |
Wand S, Klages M, Kirbach C, et al. IgM-enriched immunoglobulin attenuates systemic endotoxin activity in early severe sepsis: a before-after cohort study [J]. PLoS One, 2016, 11(8): e0160907.
|
| 67 |
Blumberg N, Cholette JM, Schmidt AE, et al. Management of Platelet Disorders and Platelet Transfusions in ICU Patients [J]. Transfus Med Rev, 2017, 31(4): 252-257.
|
| 68 |
Ning S, Barty R, Liu Y, et al. Platelet Transfusion Practices in the ICU: Data From a Large Transfusion Registry [J]. Chest, 2016, 150(3): 516-523.
|
| 69 |
Bjursten H, Al-Rashidi F, Dardashti A, et al. Risks associated with the transfusion of various blood products in aortic valve replacement [J]. Ann Thorac Surg, 2013, 96(2): 494-499.
|
| 70 |
Stanworth SJ, Walsh TS, Prescott RJ, et al. Thrombocytopenia and platelet transfusion in UK critical care: a multicenter observational study [J]. Transfusion, 2013, 53(5): 1050-1058.
|
| 71 |
World Health Organization. WHO Handbook for Reporting Results of Cancer Treatment [J]. WHO offset publication, 1979, 48: 22-28.
|
| 72 |
Estcourt LJ, Birchall J, Allard S, et al. Guidelines for the use of platelet transfusions [J]. Br J Haematol, 2017, 176(3): 365-394.
|
| 73 |
Kaufman RM, Djulbegovic B, Gernsheimer T, et al. Platelet transfusion: a clinical practice guideline from the AABB [J]. Ann Intern Med, 2015, 162(3): 205-213.
|
| 74 |
Estcourt LJ, Birchall J, Lowe D, et al. Platelet transfusions in haematology patients: are we using them appropriately? [J]. Vox Sang, 2012, 103(4): 284-293.
|
| 75 |
Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 [J]. Intensive Care Med, 2017, 43(3): 304-377.
|
| 76 |
Wandt H, Schäfer-Eckart K, Greinacher A. Platelet transfusion in hematology, oncology and surgery [J]. Dtsch Arztebl Int, 2014, 111(48): 809-815.
|
| 77 |
Zeidler K, Arn K, Senn O, et al. Optimal preprocedural platelet transfusion threshold for central venous catheter insertions in patients with thrombocytopenia [J]. Transfusion, 2011, 51(11): 2269-2276.
|
| 78 |
Estcourt LJ, Malouf R, Doree C, et al. Prophylactic platelet transfusions prior to surgery for people with a low platelet count [J]. Cochrane Database Syst Rev, 2018, 9(9): CD012779.
|
| 79 |
Warner MA, Chandran A, Frank RD, et al. Prophylactic platelet transfusions for critically ill patients with thrombocytopenia: a single-institution propensity-matched cohort study [J]. Anesth Analg, 2019, 128(2): 288-295.
|
| 80 |
Triulzi DJ, Assmann SF, Strauss RG, et al. The impact of platelet transfusion characteristics on posttransfusion platelet increments and clinical bleeding in patients with hypoproliferative thrombocytopenia [J]. Blood, 2012, 119(23): 5553-5562.
|
| 81 |
Estcourt LJ, Stanworth S, Doree C, et al. Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation [J]. Cochrane Database Syst Rev, 2015, 10(10): CD010984.
|
| 82 |
Kerrigan SW. The expanding field of platelet-bacterial interconnections [J]. Platelets, 2015, 26(4): 293-301.
|
| 83 |
Larkin CM, Santos-Martinez MJ, Ryan T, et al. Sepsis-associated thrombocytopenia [J]. Thromb Res, 2016, 141: 11-16.
|
| 84 |
Greco E, Lupia E, Bosco O, et al. Platelets and multi-organ failure in sepsis [J]. Int J Mol Sci, 2017, 18(10): 2200.
|
| 85 |
Aubron C, Flint AW, Bailey M, et al. Is platelet transfusion associated with hospital-acquired infections in critically ill patients? [J]. Crit Care, 2017, 21(1): 2.
|
| 86 |
Haesebaert J, Bénet T, Michallet M, et al. Septic shock during platelet transfusion in a patient with acute myeloid leukaemia [J]. BMJ Case Rep, 2013, 2013: bcr2013010412.
|
| 87 |
Katus MC, Szczepiorkowski ZM, Dumont LJ, et al. Safety of platelet transfusion: past, present and future [J]. Vox Sang, 2014, 107(2): 103-113.
|
| 88 |
Saini A, West AN, Harrell C, et al. Platelet Transfusions in the PICU: Does Disease Severity Matter? [J]. Pediatr Crit Care Med, 2018, 19(9): e472-e478.
|
| 89 |
Kaufman RM, Assmann SF, Triulzi DJ, et al. Transfusion-related adverse events in the Platelet Dose study [J]. Transfusion, 2015, 55(1): 144-153.
|
| 90 |
Kumawat V, Sharma RR, Malhotra P, et al. Prevalence of risk factors for platelet transfusion refractoriness in multitransfused hemato-oncological patients at tertiary care center in North India [J]. Asian J Transfus Sci, 2015, 9(1): 61-64.
|
| 91 |
Ferreira AA, Zulli R, Soares S, et al. Identification of platelet refractoriness in oncohematologic patients [J]. Clinics (Sao Paulo), 2011, 66(1): 35-40.
|